TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease

Griciuc, Ana, Patel, Shaun, Federico, Anthony N., Choi, Se Hoon, Innes, Brendan J., Oram, Mary K., Cereghetti, Gea, McGinty, Danielle +6 more·2019·Neuron

Cited by (378)

Items 101–200 of 378

  1. iPSC ‐derived microglia carrying the TREM2 R47H /+ mutation are proinflammatory and promote synapse loss
    Jay Penney, William T. Ralvenius, Anjanet R. Loon, Oyku Cerit, Vishnu Dileep, Blerta Milo, Ping‐Chieh Pao, Hannah Woolf, Li‐Huei Tsai · 2023 · Glia
  2. Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications
    Yongquan Chi, Haipeng Jiang, Yiyuan Yin, Xinyu Zhou, Yi Shao, Yongsheng Li, Jianhua Rao · 2025 · MedComm
  3. Transcriptional Networks of Microglia in Alzheimer’s Disease and Insights into Pathogenesis
    Gabriel Chew, Enrico G. Petretto · 2019 · Genes
  4. Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
    Fabiola De Marchi, Ivana Munitić, Lea Vidatic, Eliša Papić, Valentino Rački, Jerneja Nimac, Igor Jurak, Gabriela Novotni, Boris Rogelj, Vladimira Vuletić et al. · 2023 · Biomedicines
  5. Alzheimer’s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis
    Raz Dvir-Szternfeld, Giulia Castellani, Michal Arad, Liora Cahalon, Sarah Phoebeluc Colaiuta, Hadas Keren‐Shaul, Tommaso Croese, Chiara Burgaletto, Kuti Baruch, Tyler Kent Ulland et al. · 2021 · Nature Aging
  6. Novel Targets for Alzheimer's Disease: A View Beyond Amyloid
    William J. Ray, Virginie Buggia-Prévot · 2020 · Annual Review of Medicine
  7. Complement in Neurologic Disease
    Nicholas E. Propson, Manasee Gedam, Hui Zheng · 2020 · Annual Review of Pathology Mechanisms of Disease
  8. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer’s disease
    Jana, Arundhati, Wang, Xinge, Leasure, Joseph W., Magana, Lissette, Wang, Li, Kim, Young-Mee, Dodiya, Hemraj, Toth, Peter T., Sisodia, Sangram S., Rehman, Jalees · 2022 · Scientific Reports
  9. Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer’s disease
    Liang He, Yury Loika, Yongjin Park, David Alan Bennett, M Kellis, Alexander M. Kulminski, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Translational Psychiatry
  10. Meningeal immunity: Structure, function and a potential therapeutic target of neurodegenerative diseases
    Tengyun Ma, Fushun Wang, Shijun Xu, Jason Haitao Huang · 2021 · Brain Behavior and Immunity
  11. Comparative Analysis Identifies Similarities between the Human and Murine Microglial Sensomes
    Erik R. Abels, Lisa Nieland, Suzanne E. Hickman, Marike L. D. Broekman, Joseph B. El Khoury, Sybren L. N. Maas · 2021 · International Journal of Molecular Sciences
  12. Increasing phagocytosis of microglia by targeting CD33 with liposomes displaying glycan ligands
    Abhishek Bhattacherjee, Gour Chand Daskhan, Arjun Bains, Adrianne E. S. Watson, Ghazaleh Eskandari‐Sedighi, Chris D. St. Laurent, Anastassia Voronova, Matthew Scott Macauley · 2021 · Journal of Controlled Release
  13. Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s disease
    Chao Gao, Xin Shen, Yuyan Tan, Shengdi Chen · 2022 · Journal of Neuroinflammation
  14. The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial
    Catherine Jane Mummery, Arthur J. Mayorga, Adam Simmons, Tiffany W. Chow, Brady Burgess, Tuan Nguyen, 高晶晶, Balasubrahmanyam Budda, Lovingly Quitania Park, Ruchi Gupta et al. · 2026 · Nature Medicine
  15. Cerebral sterile inflammation in neurodegenerative diseases
    Otani, Kento, Shichita, Takashi · 2020 · Inflammation and Regeneration
  16. Role of the caspase-8/RIPK3 axis in Alzheimer’s disease pathogenesis and Aβ-induced NLRP3 inflammasome activation
    Sushanth Kumar, Sakar Budhathoki, Christopher B. Oliveira, August D. Kahle, O. Yipkin Calhan, John R. Lukens, Christopher D. Deppmann · 2023 · JCI Insight
  17. Autophagy Balances Neuroinflammation in Alzheimer’s Disease
    Xuehua Cheng, Yong Quek Wei, Zijun Qian, Li Han · 2022 · Cellular and Molecular Neurobiology
  18. INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
    Iguchi, Akihiro, Takatori, Sho, Kimura, Shingo, Muneto, Hiroki, Wang, Kai, Etani, Hayato, Ito, Genta, Sato, Haruaki, Hori, Yukiko, Sasaki, Junko et al. · 2023 · iScience
  19. Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses
    Kirby M. Donnelly, Olivia R DeLorenzo, Aprem Zaya, Gabrielle E Pisano, Wint M Thu, Liqun Luo, Ron R. Kopito, Margaret M.P. Pearce · 2020 · eLife
  20. Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease
    Gonzalo Ruiz‐Pérez, Samuel Ruiz de Martı́n Esteban, Sharai Marqués, Noelia Aparicio, María T. Grande, Irene Benito‐Cuesta, Ana M. Martínez-Relimpio, María Andrea Arnanz, Rosa Maria Tolón, María Posada-Ayala et al. · 2021 · Journal of Neuroinflammation
  21. Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link
    Jingqiong Hu, Xiaochuan Wang · 2022 · Frontiers in Cellular Neuroscience
  22. Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study
    Chao Ke Tang, Xiaoyang Lei, Yaqi Ding, Sushuang Yang, Yayu Ma, Dian He · 2024 · Frontiers in Immunology
  23. Microglial phagocytosis in Alzheimer disease
    Brown, Guy C., St George-Hyslop, Peter, Paolicelli, Rosa C., Lemke, Greg · 2026 · Nature Reviews Neurology
  24. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease
    Wenhui Qu, Ling Li · 2021 · The Neuroscientist
  25. Degradation of Bone Quality in a Transgenic Mouse Model of Alzheimer′s Disease
    Joan E. LLabre, Cristianel Gil, Neha Amatya, Sarita Lagalwar, Bernard P. Possidente, Deepak Vashishth · 2020 · Journal of Bone and Mineral Research
  26. Therapeutic potential of plant-derived natural compounds in Alzheimer’s disease: Targeting microglia-mediated neuroinflammation
    Yanyan Shen, Fang Liu, Mingjie Zhang · 2024 · Biomedicine & Pharmacotherapy
  27. The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
    Sara Merlo, Simona Federica Spampinato, Grazia Ilaria Caruso, Maria Angela Sortino · 2020 · Current Neuropharmacology
  28. Biological and methodological complexities of beta‐amyloid peptide: Implications for Alzheimer’s disease research
    Martyna M. Matuszyk, Claire J. Garwood, Laura Ferraiuolo, Julie E. Simpson, Rosemary A. Staniforth, Stephen B. Wharton · 2021 · Journal of Neurochemistry
  29. TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
    Xuezhen Chen, Yue Zhao, Yimin Huang, Kaichuan Zhu, Fan Zeng, Junyi Zhao, Huaqiu Zhang, Xinzhou Zhu, Helmut Kettenmann, Xianyuan Xiang · 2023 · Glia
  30. Infection and inflammation: New perspectives on Alzheimer's disease
    Heather Elizabeth Whitson, Carol A. Colton, Joseph B. El Khoury, David Gate, Alison Goate, Michael Thomas Heneka, Rima Kaddurah‐Daouk, Robyn S. Klein, Mari L. Shinohara, Sangram S. Sisodia et al. · 2022 · Brain Behavior & Immunity - Health
  31. CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer’s disease‐protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion
    Claire Ann Butler, Peter Thornton, Guy Charles Brown · 2021 · Journal of Neurochemistry
  32. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
    Li Yang Tan, Xin Yi Yeo, Han‐Gyu Bae, Delia Pei Shan Lee, Roger Ho, Jung Eun Kim, Dong‐Gyu Jo, Sangyong Jung · 2021 · Life
  33. Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
    Heather Wilson, Marios Politis, Eugenii A. Rabiner, Lefkos T. Middleton · 2020 · Cells
  34. The significance of sialylation on the pathogenesis of Alzheimer’s disease
    Kangkang Yang, Zhaofei Yang, Xiaofeng Chen, Wenzhe Li · 2021 · Brain Research Bulletin
  35. Loss of microglial EED impairs synapse density, learning, and memory
    Wang, Ying-Ying, Deng, Yu-Sen, Dai, Shang-Kun, Mi, Ting-Wei, Li, Rui-Yang, Liu, Pei-Pei, Liu, Cong, He, Bao-Dong, He, Xuan-Cheng, Du, Hong-Zhen et al. · 2022 · Molecular Psychiatry
  36. Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
    Ghazaleh Eskandari‐Sedighi, Madeline C. Crichton, Sameera Zia, Erik Gomez‐Cardona, Leonardo M. Cortez, Zain H. Patel, Kei Takahashi, Chris D. St. Laurent, Gaurav Sidhu, Susmita Sarkar et al. · 2024 · Molecular Neurodegeneration
  37. Multiomics integrative analysis identifies APOE allele-specific blood biomarkers associated to Alzheimer’s disease etiopathogenesis
    Laura Madrid, Alzheimer’s Disease Neuroimaging Initiative, Sonia Moreno–Grau, Shahzad Ahmad, Antonio González-Pérez, Itziar de Rojas, Rui Xia, Pamela V. Martino Adami, Pablo García‐González, Luca Kleineidam et al. · 2021 · Aging
  38. Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives
    Bruno Pietro Imbimbo, Madia Lozupone, Mark Watling, Francesco Panza · 2020 · Expert Opinion on Investigational Drugs
  39. A potential biomarker of preclinical Alzheimer’s disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments
    Yan Yan, Ailikemu Aierken, Chunjian Wang, Da Feng Song, Junjun Ni, Zhe Wang, Zhenzhen Quan, Hong Qing · 2021 · Neuroscience & Biobehavioral Reviews
  40. Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
    Nour S. Tobeh, Kimberley D. Bruce · 2023 · Frontiers in Aging Neuroscience
  41. Microglia and its Genetics in Alzheimer's Disease
    Xinyan Liang, Haijian Wu, Mark Colt, Xinying Guo, Brock R. Pluimer, Jianxiong Zeng, Shupeng Dong, Zhen Zhao · 2021 · Current Alzheimer Research
  42. Genomic and multi-tissue proteomic integration for understanding the biology of disease and other complex traits
    Chengran Yang, Fabiana Geraldo Farias, Laura Ibáñez, Brooke E. Sadler, María Victoria Fernández, Fengxian Wang, Joseph L. Bradley, Brett Eiffert, Jorge Alberto Bahena, John Budde et al. · 2020 · medRxiv
  43. Deciphering proteins in Alzheimer’s disease: A new Mendelian randomization method integrated with AlphaFold3 for 3D structure prediction
    Minhao Yao, Gary Wright Miller, Badri Narayan Vardarajan, Andrea Baccarelli, Zijian Guo, Zhonghua Liu · 2024 · Cell Genomics
  44. Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases
    Zheng Liu, Siyuan Song · 2025 · Genes
  45. Roles of TREM2 in Alzheimer’s disease
    Xiaokun Qi, Kedong Zhu, Wei Ke, Junjie Wang, Shanping Mao, G. Chen · 2025 · Translational Neurodegeneration
  46. Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease
    Huiying Yan, Wei Wang, Tingting Cui, Yanxin Shao, Mingquan Li, Limei Fang, Lina Feng · 2024 · ImmunoTargets and Therapy
  47. Radial glia integrin avb8 regulates cell autonomous microglial TGFβ1 signaling that is necessary for microglial identity
    Gabriel L. McKinsey, Nicolas G. Santander, Xiaoming Zhang, Kilian L. Kleemann, Lauren T Tran, Aditya Katewa, Kaylynn Conant, Matthew Barraza, Kian Waddell, Carlos O. Lizama et al. · 2025 · Nature Communications
  48. The age-related microglial transformation in Alzheimer's disease pathogenesis
    Chunxu Yuan, Ailikemu Aierken, Zhen Xie, Nuomin Li, Juan Zhao, Hong Qing · 2020 · Neurobiology of Aging
  49. Advances in Genetics and Epigenetic Alterations in Alzheimer’s Disease: A Notion for Therapeutic Treatment
    Rubén Rabaneda‐Bueno, Beatriz Mena‐Montes, Sara Torres‐Castro, Norma Torres‐Carrillo, Nora Magdalena Torres-Carrillo · 2021 · Genes
  50. Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases
    Shenglan Cheng, Bo Xiao, Zhaohui Luo · 2025 · Translational Neurodegeneration
  51. Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches
    IA Clark, Bryce Vissel · 2021 · Journal of Alzheimer s Disease
  52. Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer’s disease
    Fernández Zapata, Camila, Giacomello, Ginevra, Spruth, Eike J., Middeldorp, Jinte, Gallaccio, Gerardina, Dehlinger, Adeline, Dames, Claudia, Leman, Julia K. H., van Dijk, Roland E., Meisel, Andreas et al. · 2022 · Nature Communications
  53. Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
    Dominique Gouilly, Marie Rafiq, Léonor Nogueira, Anne‐Sophie Salabert, Pierre Payoux, Patrice Péran, Jérémie Pariente · 2023 · Revue Neurologique
  54. Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration
    Kai Chen, Fuyao Li, Shuwen Zhang, Yixing Chen, Tadafumi C. Ikezu, Zonghua Li, Yuka A. Martens, Wenhui Qiao, Axel D. Meneses, Yiyang Zhu et al. · 2025 · Journal of Neuroinflammation
  55. Immune dysfunction in Alzheimer disease
    Oleg Butovsky, Neta Rosenzweig, Kilian L. Kleemann, Mehdi Jorfi, Vijay Kumar Kuchroo, Rudolph E. Tanzi, Howard L. Weiner · 2025 · Nature reviews. Neuroscience
  56. Evaluating Effects of Glatiramer Acetate Treatment on Amyloid Deposition and Tau Phosphorylation in the 3xTg Mouse Model of Alzheimer’s Disease
    Dawling A. Dionisio-Santos, Berke Karaahmet, Elizabeth K. Belcher, Laura D. Owlett, Lee Trojanczyk, John A. Olschowka, M. Kerry O’Banion · 2021 · Frontiers in Neuroscience
  57. Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias
    Oliver Cooper, Penelope J. Hallett, Ole Isacson A · 2022 · FEBS Journal
  58. From the Mind to the Spine: The Intersecting World of Alzheimer’s and Osteoporosis
    Tyler J. Margetts, Hannah S. Wang, Sonali Jayant Karnik, Lilian Irene Plotkin, Alexandru Movilă, Adrian L. Oblak, Jill C. Fehrenbacher, Melissa A. Kacena · 2024 · Current Osteoporosis Reports
  59. TREM2+ macrophages: a key role in disease development
    Xinxin Wang, Yunhan Wang, Lei Xiang Yang, Yi Zhang, Li Yang · 2025 · Frontiers in Immunology
  60. Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer’s disease
    Zhiyu Wang, Donald Fredric Weaver · 2022 · International Immunopharmacology
  61. Hampered AMPK-ULK1 cascade in Alzheimer’s disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metformin
    A. Mary, Samantha Barale, Fanny Eysert, Audrey Valverde, Sandra Lacas-Gervais, Charlotte Bauer, S. Eddarkaoui, L. Buée, V. Buée-Scherrer, Frédéric Checler et al. · 2025 · Alzheimer's Research & Therapy
  62. Microglia in Alzheimer’s Disease
    Patrick Süß, Johannes C. M. Schlachetzki · 2020 · Current Alzheimer Research
  63. An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain
    Benjamin C. Shaw, Henry C. Snider, Andrew K. Turner, Diana J. Zajac, James F. Simpson, Steven Estus · 2022 · Journal of Alzheimer s Disease
  64. Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation-neglected multidimensional regulation of microglia
    Xin Zhang, Xue Chen, Ling Zhang, Yuqing Sun, Ying Liang, Huan Li, Yulin Zhang · 2023 · Neurochemistry International
  65. Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities
    Tobiloba Samuel Olajide, Toheeb Olalekan Oyerinde, Omolabake I. Omotosho, Oritoke Modupe Okeowo, Olayemi Joseph Olajide, Omamuyouwi M. Ijomone · 2024 · Neuroprotection/Neuroprotection (Chichester, England. Print)
  66. Investigating interleukin-8 in Alzheimer's disease: A comprehensive review
    Delia Righi, Carlo Manco, Matteo Pardini, Angela Stufano, Valentina Schino, Virginia Pelagotti, Federico Massa, Nicola De Stefano, Domenico Plantone · 2024 · Journal of Alzheimer s Disease
  67. TREM2 deficiency exacerbates cognitive impairment by aggravating α-Synuclein-induced lysosomal dysfunction in Parkinson’s disease
    Baoyu Zhu, Jiezhu Feng, Xiaomei Liang, Zhongling Fu, Mengshi Liao, Tongtong Deng, Kaicheng Wang, Jianwei Xie, Jieshan Chi, Lu Yang et al. · 2025 · Cell Death Discovery
  68. CD33 rs2455069 SNP: Correlation with Alzheimer’s Disease and Hypothesis of Functional Role
    Fabiana Tortora, Antonella Rendina, Antonella Angiolillo, Alfonso Di Costanzo, Francesco Aniello, Aldo Donizetti, Ferdinando Febbraio, Emilia Vitale · 2022 · International Journal of Molecular Sciences
  69. TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer’s disease
    Yiheng Zhao, Qian Guo, Jia Tian, Wei Liu, Xiaochuan Wang · 2024 · Ageing Research Reviews
  70. Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
    Sho Takatori, Mayuna Kondo, Taisuke Tomita · 2025 · Inflammation and Regeneration
  71. Roles of Siglecs in neurodegenerative diseases.
    Jian-Jing Siew, Y. Chern, K. Khoo, Takashi Angata · 2022 · Molecular Aspects of Medicine
  72. CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer
    Claire E. Olingy, Ahmad Alimadadi, Daniel J. Araujo, David Barry, Norma A. Gutierrez, Max Hardy-Werbin, Edurne Arriola, Sandip Pravin Patel, Christian H. H. Ottensmeier, Huy Q. Dinh et al. · 2022 · Frontiers in Immunology
  73. Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology
    Shun‐Fat Lau, Amy K.Y. Fu, Nancy Y. Ip · 2023 · Journal of Neurochemistry
  74. Genome-wide association study in Alzheimer’s disease: a bibliometric and visualization analysis
    Junyao Zhang, Yinuo Wang, Yingying Zhang, Junyan Yao · 2023 · Frontiers in Aging Neuroscience
  75. Alzheimer’s Disease Genetics: A Dampened Microglial Response?
    Zena K. Chatila, Elizabeth M. Bradshaw · 2021 · The Neuroscientist
  76. TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
    Ling Li, Xiaoxiao Zheng, Hongyue Ma, Mingxia Zhu, Xiuli Li, Xiaodan Sun, Xinhong Feng · 2025 · Cells
  77. Synthesis and Evaluation of 68Ga-NOTA-COG1410 Targeting to TREM2 of TAMs as a Specific PET Probe for Digestive Tumor Diagnosis
    Dai Shi, Zhan Si, Zhan Xu, Yuan Cheng, Qingyu Lin, Zhequan Fu, Wenhui Fu, Tingting Yang, Hongcheng Shi, Dengfeng Cheng · 2022 · Analytical Chemistry
  78. The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
    Zhen Xie, Jie Meng, Zhou Wu, Hiroshi Nakanishi, Yoshinori Hayashi, Wei Kong, Fei Lan, Narengaowa, Qinghu Yang, Hong Qing et al. · 2022 · The Neuroscientist
  79. TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment
    Gunel Ayyubova · 2023 · European Journal of Neuroscience
  80. Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer’s Disease: A Review
    Rohit Ramesh Doke, Ganesh Lamkhade, Kuldeep Vinchurkar, Sudarshan Kumar Singh · 2024 · ACS Pharmacology & Translational Science
  81. Deciphering Alzheimer’s disease: predicting new therapeutic strategies via improved understanding of biology and pathogenesis
    Rita Khoury, George Thomas Grossberg · 2020 · Expert Opinion on Therapeutic Targets
  82. Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro
    Toru Murakawa‐Hirachi, Yoshito Mizoguchi, Masahiro Ohgidani, Yoshinori Haraguchi, Akira Monji · 2021 · Scientific Reports
  83. Brain interleukins and Alzheimer’s disease
    Heba G. Abdelhamed, Arwa A. Hassan, Alaa Sakraan, Radwa T. Al-Deeb, Dalia M. Mousa, Heba S. Aboul Ezz, Neveen A. Noor, Yasser A. Khadrawy, Nasr M. Radwan · 2025 · Metabolic Brain Disease
  84. Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2021 · Neurochemistry International
  85. The past, present, and future of research on neuroinflammation-induced mild cognitive impairment: A bibliometric analysis
    Ming Cai, Yuanqi Zhang, Si Xuan Chen, Zhan Wu, Lei Zhu · 2022 · Frontiers in Aging Neuroscience
  86. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Ibanez, Kristen R., McFarland, Karen N., Phillips, Jennifer, Allen, Mariet, Lessard, Christian B., Zobel, Lillian, De La Cruz, Elsa Gonzalez, Shah, Shivani, Vo, Quan, Wang, Xue et al. · 2022 · Alzheimer's Research & Therapy
  87. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer’s Disease
    Grazia Daniela Femminella, Alzheimer’s Disease Neuroimaging Initiative, Denise H. Harold, James Scott, Julie H. Williams, Paul Edison · 2020 · Journal of Alzheimer s Disease
  88. MAMDC2, a gene highly expressed in microglia in experimental models of Alzheimers Disease, positively regulates the innate antiviral response during neurotropic virus infection
    Wang, Yiliang, Luo, Weisheng, Wang, Xiaohui, Ma, Yuying, Huang, Lianzhou, Wang, Yifei · 2022 · Journal of Infection
  89. Molecular mechanisms of Alzheimer’s disease: From therapeutic targets to promising drugs
    Alan, Elif, Kerry, Zeliha, Sevin, Gulnur · 2023 · Fundamental & Clinical Pharmacology
  90. Microglia and neuroinflammation: function, heterogeneity, and crosstalk
    Shuai Zong, Xiaolin Cui, Shuang Wu, Zhiming Lu · 2026 · Cellular and Molecular Immunology
  91. CD33/TREM2 Signaling Mediates Sleep Deprivation-Induced Memory Impairment by Regulating Microglial Phagocytosis
    Shuwen Tan, Hui Gao, Jianyu Sun, Na Li, Yuxin Zhang, Liu Yang, Min Wang, Qiang Wang, Qian Zhai · 2023 · NeuroMolecular Medicine
  92. Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
    Annie Y. Yao, Patrick J. Halloran, Yingying Ge, Neeraj Singh, John Zhou, James Galske, Wanxia He, Riqiang Yan, Xiangyou Hu · 2023 · Journal of Neuroscience
  93. Brazilian green propolis prevent Alzheimer’s disease-like cognitive impairment induced by amyloid beta in mice
    Takashi K. Ito, Tomomi Degawa, Nobuaki Okumura · 2023 · BMC Complementary Medicine and Therapies
  94. Pra-C exerts analgesic effect through inhibiting microglial activation in anterior cingulate cortex in complete Freund’s adjuvant-induced mouse model
    Dan‐Jie Su, Longfei Li, Saiying Wang, Qi Yang, Yujing Wu, Ming Zhao, Le Yang · 2021 · Molecular Pain
  95. Adhesion G protein-coupled receptor ADGRG1 promotes protective microglial response in Alzheimer’s disease
    Beika Zhu, Andi Wangzhou, Diankun Yu, Tao Li, Rachael Schmidt, Stacy L. De Florencio, Lauren Chao, Alicia L Thurber, Minqi Zhou, Zeina Msheik et al. · 2024 · Neuron
  96. Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets
    Eugenia A. Ahremenko, Alexander Andreev, Danila Apushkin, Eduard Korkotian · 2025 · International Journal of Molecular Sciences
  97. TREM2 in neurodegeneration and diseases
    Abdulkhaliq, Altaf A., Alasiri, Glowi, Kim, Bonglee, Khan, Johra, Ajoolabady, Amir, Yousof, Shimaa Mohammad, Ren, Jun, Tuomilehto, Jaakko, Borai, Anwar, Alrfaei, Bahauddeen M. et al. · 2026 · Molecular Psychiatry
  98. CARD9 attenuates Aβ pathology and modifies microglial responses in an Alzheimer’s disease mouse model
    Hannah E Ennerfelt, Coco Holliday, Daniel A. Shapiro, Kristine E. Zengeler, Ashley C. Bolte, T. Ulland, John R. Lukens · 2023 · Proceedings of the National Academy of Sciences of the United States of America
  99. Human stem cell transplantation models of Alzheimer’s disease
    Nkechime Ifediora, Peter Canoll, Gunnar Hargus · 2024 · Frontiers in Aging Neuroscience
  100. Boosting of tau protein aggregation by CD40 and CD48 gene expression in Alzheimer's disease
    Sung‐Hyun Kim, Key‐Hwan Lim, Sumin Yang, Jae‐Yeol Joo · 2022 · The FASEB Journal